Antioxidant Defenses Confer Resistance to High Dose Melphalan in Multiple Myeloma Cells

Background: Multiple myeloma (MM) is the second most common hematological cancer after lymphoma. It is characterized by the accumulation of clonal malignant plasma cells within the bone marrow. The development of drug resistance remains a major problem for effective treatment of MM. Understand the m...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancers (Basel)
Huvudupphovsmän: Gourzones, Claire, Bellanger, Céline, Lamure, Sylvain, Gadacha, Ouissem Karmous, De Paco, Elvira Garcia, Vincent, Laure, Cartron, Guillaume, Klein, Bernard, Moreaux, Jérôme
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2019
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6521290/
https://ncbi.nlm.nih.gov/pubmed/30925767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11040439
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk